Canmab 440 Mg
Approx. Price: Rs 16,500 / PER vialGet Latest Price
Product Details:
Packaging Size | 440 MG |
Brand | CANMAB |
Composition | TRASTUZUMAB |
Manufacturer | BIOCON |
Treatment | breast cancer |
Prescription/Non prescription | Prescription |
Form | Injection |
Strength | 440mg |
Country of Origin | Made in India |
CANMAb™ is a targeted therapy for the treatment of HER2-positive breast cancer and acts by interfering with HER2 protein production and stopping the growth of cancer cells. It is easy to administer and will be given intravenously, once every 3 weeks or on a weekly basis depending on the patient's condition.
Yes! I am Interested